Home > Research > Clinical Trials > Phase I Trials > Phase 1 Trials Current

Phase I Trials Current

Study Study description Investigator Study Coordinator

Protocol C-035-456.

(AERAS 456)

Phase 1/11a Double-Blind , Randomized , Placebo-Controlled, Dose-Finding Study to Evaluate the Safety and Immunogenicity of AERAS-456 in HIV negative Adults with and without Latent Tuberculosis Infection. Age 18-50. Angelique Luabaya. Rachel Oelofse